LONDON--(BUSINESS WIRE)--The autologous cell therapy market is poised to grow by USD 1.97 bn during 2020-2024 progressing, at a CAGR of almost 22% during the forecast period.
Worried about the impact of COVID-19 on your Business? Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.
Get FREE Sample Report in Minutes!
The report on the autologous cell therapy market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the use of biomass as a fuel in boilers.
The autologous cell therapy market analysis includes the therapy segment, application segment, and geography landscape. This study identifies the increasing demand for effective drugs for cardiac and degenerative disorders as one of the prime reasons driving the autologous cell therapy market growth during the next few years.
This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The autologous cell therapy market covers the following areas:
Autologous Cell Therapy Market Sizing
Autologous Cell Therapy Market Forecast
Autologous Cell Therapy Market Analysis
Companies Mentioned
- Bayer AG
- Brainstorm Cell Therapeutics Inc.
- Daiichi Sankyo Co. Ltd.
- FUJIFILM Holdings Corp.
- Holostem Terapie Avanzate Srl
- Osiris Therapeutics Inc.
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Sumitomo Chemical Co. Ltd.
- Vericel Corp.
Related Reports on Health Care Include:
-
Aspergillosis Drugs Market by Product and Geography - Forecast and Analysis 2020-2024- The aspergillosis drugs market size has the potential to grow by USD 658.48 million during 2020-2024, and the market’s growth momentum will accelerate during the forecast period. To get extensive research insights: Click and get FREE sample report in minutes
-
Diabetic Foot Ulcers Therapeutics Market by Product and Geography - Forecast and Analysis 2020-2024- The diabetic foot ulcers therapeutics market size has the potential to grow by USD 986.41 million during 2020-2024, and the market’s growth momentum will accelerate during the forecast period. To get extensive research insights: Click and get FREE sample report in minutes
Key Topics Covered:
Executive Summary
- Market Overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Therapy
- Market segments
- Comparison by Therapy placement
- Autologous stem cell therapy - Market size and forecast 2019-2024
- Autologous cellular immunotherapies - Market size and forecast 2019-2024
- Market opportunity by Therapy
Customer landscape
- Overview
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- APAC - Market size and forecast 2019-2024
- South America - Market size and forecast 2019-2024
- MEA - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
Drivers, Challenges, and Trends
- Market drivers
- Volume driver - Demand led growth
- Volume driver - Supply led growth
- Volume driver - External factors
- Volume driver - Demand shift in adjacent markets
- Price driver - Inflation
- Price driver - Shift from lower to higher-priced units
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Landscape disruption
- Vendor Analysis
Vendors covered
- Market positioning of vendors
- Bayer AG
- Brainstorm Cell Therapeutics Inc.
- Daiichi Sankyo Co. Ltd.
- FUJIFILM Holdings Corp.
- Holostem Terapie Avanzate Srl
- Osiris Therapeutics Inc.
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Sumitomo Chemical Co. Ltd.
- Vericel Corp.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
